The relationship between the cholesterol-low density lipoprotein/cholesterol-high density lipoprotein ratio with the incidence of acute coronary syndrome at RSUD kota Bandung in 2019-2022
Keywords:
Low Cholesterol Ratio, High Cholesterol, Lipoprotein Density,, Acute Coronary SyndromeAbstract
The purpose of this study was to understand K-LDL levels with the incidence of acute coronary syndrome (ACS) in patients at the RSUD Kota Bandung Regional General Hospital (RSUD). The method used is a descriptive analytical method through a cross sectional approach to observe the Correlation of K-LDL/K-HDL Ratio with ACS (Acute Coronary Syndrome) events. The results of this study show that there is a correlation between the K-LDL/K-HDL ratio and ACS events at RSUD Kota Bandung in 2019 – 2021, this result can be concluded because it obtained a p value = 0.045. First, the majority of ACS patients at RSUD Kota Bandung in 2019 – 2021 are men, 65.6% of the total patients. Second, as many as 70.8% of the total patients of this study were active smokers. Third, the type of SKA that dominated in this study patient was APTS with 63.5% of the total respondents. Fourth, the average age of patients in these patients was 55.70 years. Fifth, the average ratio of LDL / HDL to ACS sufferers at RSUD Kota Bandung in 2019-2022 is 3,271. Sixth, the maximum and minimum values of LDL/HDL ratio in ACS patients at RSUD Kota Bandung in 2019 - 2022 are 7.037 and 0.215.
References
N. D. Wong, “Epidemiological studies of CHD and the evolution of preventive cardiology,” Nat. Rev. Cardiol., vol. 11, no. 5, pp. 276–289, 2014.
Organização Mundial de Saúde., “World health statistics 2022 (Monitoring health of the SDGs),” Monit. Heal. SDGs., 2022.
A. P. Sunjaya, A. F. Sunjaya, and A. Priyana, “Insights and challenges of indonesia’s acute coronary syndrome telecardiology network: three year experience from a single center and in west Jakarta, Indonesia,” in IOP Conference Series: Materials Science and Engineering, IOP Publishing, 2019, p. 12142.
J. Q. Xu, S. L. Murphy, K. D. Kochanek, and E. Arias, “Mortality in the United States, 2018. NCHS Data Brief, no 355. Hyattsville, MD: National Center for Health Statistics. 2020.” 2021.
A. Maharani, Sujarwoto, D. Praveen, D. Oceandy, G. Tampubolon, and A. Patel, “Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study,” PLoS One, vol. 14, no. 4, p. e0215219, 2019.
T. Ryan, Cooper, Profil Kesehatan Indonesia 2020. Paper Knowledge . Toward a Media History of Documents., 2020.
A. R. Ekaputra, M. R. Akbar, and L. A. Garina, “Hubungan Indeks Massa Tubuh dengan Fraksi Ejeksi Ventrikel Kiri pada Pasien Sindrom Koroner Akut,” Pros. Pendidik. Dr., pp. 760–765, 2015.
J. Brier, “lia dwi jayanti,“,” Implmentasi Layanan Deliv. Libr. Search. Serv. Sebagai Layanan Ref. Virtual Perpust. Univ. Syiah Kuala,” Libr., vol. 21, no. 1, pp. 1–9, 2020.
T. P. Varghese and A. V Kumar, “Predisposing risk factors of acute coronary syndrome (ACS): A mini review,” J. Pharm. Sci. Res., vol. 11, no. 5, pp. 1999–2002, 2019.
R. Hajar, “Risk factors for coronary artery disease: historical perspectives,” Hear. views Off. J. Gulf Hear. Assoc., vol. 18, no. 3, p. 109, 2017.
S. S. Virani et al., “Heart disease and stroke statistics—2020 update: a report from the American Heart Association,” Circulation, vol. 141, no. 9, pp. e139–e596, 2020.
G. H Tomkin and D. Owens, “LDL as a cause of atherosclerosis,” Open Atheroscler. Thromb. J., vol. 5, no. 1, 2012.
T. Quertermous and E. Ingelsson, “Coronary artery disease and its risk factors: leveraging shared genetics to discover novel biology,” Circulation Research, vol. 118, no. 1. Am Heart Assoc, pp. 14–16, 2016.
lia dwi jayanti. L. S. L. Brier J, Pathophysiology of Heart Disease 5. 2022.
W. Hao and A. Friedman, “The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model,” PLoS One, vol. 9, no. 3, p. e90497, 2014.
N. Uppal, V. Uppal, and P. Uppal, “Progression of coronary artery disease (CAD) from stable angina (SA) towards myocardial infarction (MI): role of oxidative stress,” J. Clin. diagnostic Res. JCDR, vol. 8, no. 2, p. 40, 2014.
Á. Hernáez et al., “Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination,” PLoS One, vol. 14, no. 6, p. e0218533, 2019.
Á. Hernáez Camba et al., “Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination,” PLoS One, 2019, vol. 14, num. 6, p. e0218533, 2019.
D. Li and J. L. Mehta, “Oxidized LDL, a critical factor in atherogenesis,” Cardiovascular research, vol. 68, no. 3. Elsevier Science, pp. 353–354, 2005.
Z. Zhong et al., “Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation,” Lipids Health Dis., vol. 18, no. 1, pp. 1–8, 2019.
N. Kurebayashi et al., “Impact of the low-to high-density lipoprotein cholesterol ratio on composition of angiographically ambiguous left main coronary artery plaque,” Circ. J., vol. 75, no. 8, pp. 1960–1967, 2011.
E. A. Amsterdam et al., “2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 130, no. 25, pp. 2354–2394, 2014.
R. S. Rosenson, H. B. Brewer, and D. J. Rader, “Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome,” Circ. Res., vol. 114, no. 12, pp. 1880–1889, 2014.
S. Chou, C. W. Chen, and Y. T. Kuo, “Flexibility, collaboration and relationship quality in the logistics service industry: An empirical study,” Asia Pacific J. Mark. Logist., vol. 30, no. 3, pp. 555–570, 2018, doi: 10.1108/APJML-08-2017-0170.
F. de Galiza Barbosa et al., “Genitourinary imaging,” in Clinical PET/MRI, Elsevier, 2023, pp. 289–312.
Y. Pan, S. Sheng, and F. T. Xie, “Antecedents of customer loyalty: An empirical synthesis and reexamination,” J. Retail. Consum. Serv., vol. 19, no. 1, pp. 150–158, 2012, doi: 10.1016/j.jretconser.2011.11.004.
J. A. Fernandez-Higuero, A. M. Salvador, C. Martín, J. C. G. Milicua, and J. L. R. Arrondo, “Human LDL structural diversity studied by IR spectroscopy,” PLoS One, vol. 9, no. 3, p. e92426, 2014.
T. Hevonoja, M. O. Pentikäinen, M. T. Hyvönen, P. T. Kovanen, and M. Ala-Korpela, “Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL,” Biochim. Biophys. Acta (BBA)-Molecular cell Biol. lipids, vol. 1488, no. 3, pp. 189–210, 2000.